Sponsor:
University of Pennsylvania
Code:
NCT07444203
Conditions
Diabetic Nephropathies
Kidney Diseases
Renal Insufficiency, Chronic
Diabetes Mellitus, Type 2
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
Sodium-glucose cotransporter 2 inhibitors (SGLT2i)
Renin-angiotensin-aldosterone system blockade
Glucagon-like peptide-1 receptor agonists (GLP 1 RA)
Mineralocorticoid Receptor Antagonists(MRAs)
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-03-12. This information was provided to ClinicalTrials.gov by University of Pennsylvania on 2026-03-02.